Uncategorized
Global Choroidal Neovascularization Therapeutics Report 2016: Pipeline Review of 8 Companies & 16 Drug Molecules – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Choroidal Neovascularization - Pipeline Review, H2 2016" report to their offering. Choroidal neovascularization (CNV) involves the growth of new blood vessels that originate from the choroid Symptoms include painless loss of vision, metamorphopsia, and color disturbances. Treatment includes ant-VEGF agents, laser photocoagulation and photodynamic therapy. Choroidal Neovascularization pipeline therapeutics constitut
